GenWealth Group’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $968K | Sell |
3,813
-15
| -0.4% | -$3.5K | 0.15% | 43 |
|
|
2026
Q1 | $936K | Sell |
3,828
-22
| -0.6% | -$5.12K | 0.16% | 41 |
|
|
2025
Q4 | $788K | Buy |
3,850
+284
| +8% | +$56.2K | 0.13% | 47 |
|
|
2025
Q3 | $661K | Buy |
3,566
+4
| +0.1% | +$685 | 0.12% | 45 |
|
|
2025
Q2 | $544K | Sell |
3,562
-69
| -2% | -$10.6K | 0.11% | 46 |
|
|
2025
Q1 | $602K | Buy |
3,631
+748
| +26% | +$117K | 0.13% | 43 |
|
|
2024
Q4 | $417K | Sell |
2,883
-5
| -0.2% | -$775 | 0.09% | 49 |
|
|
2024
Q3 | $468K | Sell |
2,888
-45
| -2% | -$7.17K | 0.11% | 51 |
|
|
2024
Q2 | $429K | Buy |
2,933
+6
| +0.2% | +$892 | 0.11% | 50 |
|
|
2024
Q1 | $463K | Sell |
2,927
-53
| -2% | -$8.44K | 0.12% | 48 |
|
|
2023
Q4 | $467K | Sell |
2,980
-172
| -5% | -$26.4K | 0.13% | 52 |
|
|
2023
Q3 | $491K | Buy |
3,152
+4
| +0.1% | +$660 | 0.15% | 49 |
|
|
2023
Q2 | $521K | Buy |
3,148
+5
| +0.2% | +$807 | 0.15% | 51 |
|
|
2023
Q1 | $487K | Sell |
3,143
-12
| -0.4% | -$1.94K | 0.15% | 49 |
|
|
2022
Q4 | $557K | Buy |
3,155
+4
| +0.1% | +$691 | 0.18% | 49 |
|
|
2022
Q3 | $515K | Sell |
3,151
-33
| -1% | -$5.58K | 0.17% | 37 |
|
|
2022
Q2 | $565K | Buy |
3,184
+4
| +0.1% | +$713 | 0.18% | 34 |
|
|
2022
Q1 | $564K | Buy |
3,180
+4
| +0.1% | +$681 | 0.16% | 40 |
|
|
2021
Q4 | $543K | Sell |
3,176
-100
| -3% | -$16.4K | 0.15% | 43 |
|
|
2021
Q3 | $529K | Sell |
3,276
-21
| -0.6% | -$3.58K | 0.16% | 38 |
|
|
2021
Q2 | $543K | Buy |
3,297
+4
| +0.1% | +$662 | 0.16% | 38 |
|
|
2021
Q1 | $541K | Buy |
3,293
+4
| +0.1% | +$647 | 0.17% | 40 |
|
|
2020
Q4 | $518K | Sell |
3,289
-96
| -3% | -$14.2K | 0.17% | 42 |
|
|
2020
Q3 | $501K | Sell |
3,385
-415
| -11% | -$61.4K | 0.18% | 42 |
|
|
2020
Q2 | $533K | Buy |
3,800
+1,000
| +36% | +$146K | 0.21% | 41 |
|
|
2020
Q1 | $367K | Sell |
2,800
-9
| -0.3% | -$1.28K | 0.16% | 39 |
|
|
2019
Q4 | $409K | Hold |
2,809
| – | – | 0.16% | 49 |
|
|
2019
Q3 | $363K | Hold |
2,809
| – | – | 0.15% | 53 |
|
|
2019
Q2 | $393K | Buy |
2,809
+9
| +0.3% | +$1.25K | 0.17% | 49 |
|
|
2019
Q1 | $389K | Buy |
2,800
+275
| +11% | +$36.8K | 0.18% | 46 |
|
|
2018
Q4 | $325K | Sell |
2,525
-555
| -18% | -$77.4K | 0.16% | 45 |
|
|
2018
Q3 | $432K | Buy |
3,080
+177
| +6% | +$23.5K | 0.2% | 42 |
|
|
2018
Q2 | $356K | Buy |
2,903
+140
| +5% | +$17.5K | 0.17% | 46 |
|
|
2018
Q1 | $354K | Buy |
2,763
+38
| +1% | +$5.14K | 0.18% | 45 |
|
|
2017
Q4 | $403K | Sell |
2,725
-85
| -3% | -$11.8K | 0.2% | 47 |
|
|
2017
Q3 | $365K | Hold |
2,810
| – | – | 0.22% | 42 |
|
|
2017
Q2 | $371K | Buy |
+2,810
| New | +$358K | 0.25% | 37 |
|
Other funds holding JNJ
GenWealth Group's JNJ Position: Q2 2026 in Review
GenWealth Group reduced its Johnson & Johnson (JNJ) stake by 0.39% in Q2 2026, selling an estimated $3.5K and leaving 3,813 shares worth $968K. The position accounts for 0.15% of the portfolio, ranked #43.
GenWealth Group first reported a position in JNJ in Q2 2017 and has held it in 37 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- GenWealth Group held 3,813 shares of Johnson & Johnson worth $968K as of Q2 2026.
- GenWealth Group sold 15 Johnson & Johnson shares in Q2 2026, an estimated $3.5K.
- Johnson & Johnson made up 0.15% of GenWealth Group's portfolio in Q2 2026, its #43 holding.
- GenWealth Group first reported a position in Johnson & Johnson in Q2 2017 and has held it in 37 quarters since.
- 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on GenWealth Group's 13F filing for Q2 2026, filed 10 Jul 2026.